ONTERA INC.
Portable nanopore-based diagnostic device for detecting Hepatitis C virus core antigen biomarkers in blood samples
- Sector
- Medtech
- Headquarters
- SANTA CRUZ, CA
- Founded
- 2011
- Latest Form D
- $20.5M, Aug 2020
- Total capital
- $33.7M
- Federal grants
- $482K
- 2 awards · 2016
- Rank in peer group#235 of 445
- Private capital raised
- $33.2M
- 4 Form D · last Aug 2020
- 75 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 11
- 22 pending · first 2019
- Rank in peer group#17 of 445
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$20.5M
- Private capital raisedForm D · SEC · 3rd filing$2.9M
- Private capital raisedForm D · SEC · 2nd filing$4.6M
- Federal grantHealth and Human S · Phase I · A Platform Approach for the Electrical Detection of Protein Biomarkers using a Nanopore Device$257K
- Federal grantHealth and Human S · Phase I · Diagnosing Active Hepatitis C Virus Infection by Electrical Detection of Protein Biomarkers using a Nanopore Device$225K
- Private capital raisedForm D · SEC · 1st filing$5.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 445 peers
Line = medianMedtech · Device
- Federal grantsBelow median
- Granted patents#17 · top 4%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Daniel HellerDirectorNamed in SEC Form D filings
- George HaraDirectorNamed in SEC Form D filings
- Murielle Thinard-McLaneExecutive Officer, DirectorNamed in SEC Form D filings
- Rajesh SwaminathanDirectorNamed in SEC Form D filings
What it has protected
USPTO · 11 granted of 33- GrantedTarget Detection with NanoporeUSPTOUS 12,429,481
- GrantedSensing Compositions, Methods, And Devices For The Detection Of Molecules Using A Nanopore DeviceUSPTOUS 12,188,899
- GrantedMultipore Determination Of Fractional Abundance Of Polynucleotide Sequences In A SampleUSPTOUS 11,486,873
Show all 33 patent records
- Target Detection with NanoporeSep 30, 2025 · US 12,429,481Granted
- Sensing Compositions, Methods, And Devices For The Detection Of Molecules Using A Nanopore DeviceJan 7, 2025 · US 12,188,899Granted
- Multipore Determination Of Fractional Abundance Of Polynucleotide Sequences In A SampleNov 1, 2022 · US 11,486,873Granted
- Fractional Abundance Of Polynucleotide Sequences In A SampleSep 6, 2022 · US 11,435,338Granted
- Relative Quantification Of Genetic Variants In A SampleJun 9, 2022 · Application 17437028Pending
- Photonic Thermocycling Devices And MethodsSep 30, 2021 · Application 17211750Pending
- Nanopore Detection Of Target Polynucleotides From Sample BackgroundAug 24, 2021 · US 11,098,348Granted
- Device with Flow Features for Sample Processing and Method of UseAug 5, 2021 · Application 17133163Pending
- Target Detection with Nanopore and a Polymer Scaffold ComplexDec 22, 2020 · US 10,871,482Granted
- Nanopore Detection of Small Molecules Through Competition AssaysNov 17, 2020 · US 10,837,954Granted
- Target Detection With NanoporeJun 2, 2020 · US 10,670,590Granted
- Molecule Detection Using Boronic Acid Substituted ProbesMar 24, 2020 · US 10,597,702Granted
- Multiplexed Biomarker Quantitation By Nanopore Analysis Of Biomarker-polymer ComplexesDec 3, 2019 · US 10,495,628Granted
- Wafer-Scale Assembly of Insulator-Membrane-Insulator Devices for Nanopore SensingNov 26, 2019 · US 10,488,394Granted
- Methods and Compositions for Target Detection in a Nanopore Using a Labelled Polymer ScaffoldDec 20, 2018 · Application 15573630Pending
- Target Modification For Tracking And DetectionNov 15, 2018 · Application 15775783Pending
- Labile Linkers for Biomarker DetectionJan 25, 2018 · Application 15547439Pending
- Scaffold Data Storage and Target Detection in a Sample Using a NanoporeMar 16, 2017 · Application 15310426Pending
- Target Detection with NanoporeSep 8, 2016 · Application 15160697Pending
- Relative Quantification of Genetic Variants in a SampleApplication 62815763Pending
- Devices And Methods For Detecting Target Polynucleotides Using A Nanopore DeviceApplication 63220405Pending
- Photonic Thermocycling Devices And MethodsApplication PCTUS2021024009Pending
- Devices And Methods For Analyzing Fractional Amounts Of Target Polynucleotides Using A Nanopore DeviceApplication 63081303Pending
- Photonic Polymerase Chain Reaction and Temperature SensingApplication 63000143Pending
- Relative Quantification Of Genetic Variants In A SampleApplication PCTUS2020021233Pending
- Device With Flow Features For Sample Processing And Method Of UseApplication 62968281Pending
- Relative Quantification Of Genetic Variants In A SampleApplication 62933935Pending
- Sensing Compositions, Methods And Devices For The Detection Of Molecules Using A Nanopore DeviceApplication PCTUS2019050087Pending
- Multipore Determination Of Fractional Abundance Of Polynucleotide Sequences In A SampleApplication PCTUS2019028518Pending
- Methods For Accurate And Reproducible Detection And Quantification Of Target Polynucleotides Using A Nanopore DeviceApplication PCTUS2021051366Pending
- Optimized Buffers For Nanopore Detection Of Small Molecules In Larger NanoporesApplication 62728672Pending
- Optimized buffers for nanopore detection of small molecules in larger nanoporesApplication 62728584Pending
- Dual Pore-control And Sensor DeviceApplication PCTUS2018037634Pending
Related companies, and why
- Definitive Biotechnologies LLCSimilar federal contract value in Medtech · null in contracts
- RETHAM TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
- BURST DIAGNOSTICS LLCSimilar federal contract value in Medtech · null in contracts
- FirstVitals Inc.Similar federal contract value in Medtech · null in contracts
- DIADEM US, INC.Similar federal contract value in Medtech · null in contracts
- RECOVERY FORCE, LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .